6. Parkinson disease Clinical trials / Disease details


Clinical trials : 2,298 Drugs : 2,202 - (DrugBank : 350) / Drug target genes : 188 - Drug target pathways : 202

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05056194
(ClinicalTrials.gov)
November 1, 202117/9/2021Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease StudyA Double-blind, Randomized, Placebo-controlled, Parallel, Study to Assess the Efficacy and Safety of XW10172 MR for the Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's DiseaseParkinson Disease;Excessive Daytime SomnolenceDrug: Valiloxybate;Other: PlaceboXWPharmaNULLNot yet recruiting40 Years75 YearsAll70Phase 2NULL